Industry Leaders Share Optimism on the Region’s Life Sciences Economic Outlook Amid Recession Concerns

Published on :

To discuss how the Biohealth Capital Region would fare out in a potential recession, and whether it can actually avoid one, the I-270 Innovation Labs brought together an outstanding group of regional experts from across key sectors connected to both industries.

REGENXBIO on Why It’s Better Here

Published on :

For Curran Simpson, Chief Operations and Technology Officer at REGENXBIO, Maryland has the “ideal mix” of talent for process development and manufacturing. Because if that, it was a no-brainer for the company to opening of its new Manufacturing Innovation Center gene therapy manufacturing facility in Rockville.
The new 132,000 square-foot-facility was designed to boost manufacturing of the company’s NAV Technology-based adeno-associated virus (AAV) vectors at scales up to 2,000 liters. REGENXBIO’s AAV vector platform has been licensed to other companies and was used in the development of Novartis’ Zolgensma, a gene therapy for spinal muscular atrophy. With its new site that includes two independent bulk drug substance production suites, a final drug product suite and integrated quality control labs, REGENXBIO is one of only a few gene therapy companies worldwide with a GMP facility capable of production at scales up to 2,000 liters.

Cartesian, BD and REGENXBIO’s Ken Mills Take Home Top Honors at MTC’s Industry Awards Celebration

Published on :

The Maryland Tech Council, the largest technology and life science trade association in the state, announced the winners of its 2022 Industry Awards Thursday at the Bethesda North Marriott Hotel & Conference Center. The event, which honored companies, executives, students, and educators in 15 categories, marked the first in-person gathering for the Industry Awards Celebration since 2019. 

Maryland Tech Council Secures $2.5 Million for Life Science Workforce Development Through BioHub Maryland

Published on :

The Maryland Tech Council, the largest technology and life science trade association in the state, announced today it has secured $2.5 million in state funding to grow the state’s life science workforce through its BioHub Maryland program. The funding is included in Governor Larry Hogan’s new Maryland Cancer Moonshot Initiative to expand and accelerate cancer detection, screening, prevention, treatment, and research in the state.

Governor Hogan Announces Maryland Cancer Moonshot Initiative; $216 Million in Initial Investments in Comprehensive Cancer Centers, Cutting-Edge Research of Treatments and Cures

Published on :

Governor Larry Hogan today announced a new Maryland Cancer Moonshot Initiative to expand and accelerate cancer detection, screening, prevention, treatment, and research in the state. The state is committing $216 million in investments as a down payment to jumpstart this far-reaching initiative to save lives, including the first ever comprehensive cancer center in Prince George’s County.

AGT, NextCure & Vita Therapeutics’s Douglas Falk Among MTC 2022 Industry Awards Finalists

Published on :

FREDERICK, Md.–(BUSINESS WIRE)–The Maryland Tech Council is proud to announce the finalists for its annual Industry Awards Celebration. The event honors individuals and companies in the life sciences, technology, and government contracting industries that have made a significant impact in their respective fields. For the first time in two years, the awards ceremony will be held in person, with the winners announced live on May 12th at the Bethesda North Marriott Hotel & Conference Center. Last year over 9,000 people tuned in to the virtual Industry Awards Celebration. Click here to learn more about the event. 
“We are thrilled to be returning in person for this year’s Industry Awards. It’s a terrific opportunity to recognize our colleagues for their contributions over the past year, and there is no substitute for live events,” said IAC committee Co-Chair and Business Development Leader, Atlantic Region at BDO, Tony DeFlumeri.

Biotech Careers: Everyone Can Take Part in Shaping the Future

Maryland has built “one of the nation’s strongest life sciences industries”.
Published on :

The growing life sciences ecosystem in Maryland has become a shining star in the BioHealth Capital Region. The region has seen explosive growth driven by billions of federal dollars aimed at R&D efforts to combat the COVID-19 threat. And that continued growth has become a magnet for a robust supply of life sciences talent that will continue to shape the future of the state and region.

New Report Highlights Maryland Life Sciences’ National Strengths, Opportunities for Growth

Published on :

A new independent study finds that Maryland has built “one of the nation’s strongest life sciences industries” that directly employs more than 54,000 workers in the state. The report from the globally recognized Milken Institute also identifies new opportunities for the public and private sectors to enhance Maryland’s entrepreneurial ecosystem and to strengthen its workforce development strategies.

5 Can’t Miss Q4 Events for Biotech Professionals in 2021

Published on :

What’s up, everybody?  My name’s Jake Greenwood and if you’re not aware, I have a weekly segment on LinkedIn called #WannaGoWednesday where I highlight upcoming Life Sciences Industry events in the BioHealth Capital Region and beyond.  Very often I’m looking at BioBuzz to see what those upcoming events might be.  Well, the good folks leading the community at BioBuzz have invited me to invade their platform and share the can’t miss events for the remainder of 2021. 

8 TEDCO Talks for Biotech and Life Science Enthusiasts in the BHCR

Published on :

TEDCO Talks’, a video series launched by TEDCO in November 2020, serves as a platform for individuals to hear from thought leaders on economic development in the BioHealth Capital Region (BHCR), and particularly in Maryland. These 30-minute virtual ‘fireside chats’ cover a range of topics, such as advice to small businesses dealing with COVID-19, available funding programs and benefits, diversity and inclusion, and more.